A method is described for the reliable, fast, and relatively inexpensive fractionation of plasma lipoproteins and quantitation of their cholesterol content. This procedure requires 350 zl of plasma and can be completed within 3 h. Plasma lipoproteins(175 l of plasma) were prestained with Fat Red 7B and centrifuged (Beckman Airfuge) at plasma density (d = 1.006 kg/liter) and at a solvent density of 1.060 kg/liter, adjusted by adding solid KBr. Prestained centrifuged samples demonstrated the characteristic elevation of chylomicrons in phenotypes I and V, low-density lipoproteins of phenotype II, very-low-density lipoproteins in phenotype IV and V. and a continuum of pink color throughout the centrifuge tube, diagnostic of the floating beta lipoprotein of type Ill. Centrifuged samples were separated into top and bottom fractions by aspiration. Hypercholesterolemiais a well-recognized risk factor for the development of atherosclerosis.
Cholesterol was quantitated with an enzymic oxygenelectrode analyzer (Beckman Cholesterol Analyzer).
The abovenormal plasma cholesterol associated with premature cardiovascular disease is carried primarily with the low-density lipoproteins (LDL)' (1) . Recently, retrospective analysis of epidemological data has established an inverse correlation between decreased cholesterol concentrations in HDL and premature heart disease (2) (3) (4) (5) . It is apparent that if individuals with an increased Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. 20014.
'Nonstandard abbreviations used: HDL, high-density lipoproteins; LDL, low-density lipoproteins; VLDL, very-low-density lipoproteins; LRC, Lipid Research Clinics. ReceivedMay 24,1977 ; accepted Sept. 1, 1977. risk of premature heart disease are to be clearly identified, cholesterol concentrations in both HDL and LDL must be ascertained.
Currently, plasma lipoproteins are measured by methods standardized by the LRC (6) . Plasma lipoproteins are fractionated by ultracentrifugation (5 ml of plasma) and precipitated with heparin/manganese chloride (2 ml of plasma). The cholesterol in plasma and lipoprotein fractions is quantitated with a Technicon AutoAnalyzer II with use of the Liebermann-Burchard reagent after zeolite isopropranol extraction. The LRC methodology has been used extensively to identify patients with hyperlipoproteinemia and to classify these patients into phenotypes I-V (7). However, the cost of the equipment and time required for analysis makes this methodology impractical for the clinical laboratory.
Materials and Methods

Plasma Samples
Plasma collected for analysis was obtained by venipuncture from fasting (12-16 h) subjects and anticoagulated with disodium edetate (1 g/liter). Samples were cooled on ice immediately after collection and centrifuged (IEC Model PR-2; International Equipment Co., Needham Heights, Mass. 02194) at 1500 X g for 30 mm at 4 #{176}C. Centrifuged plasma was separated from cells with a Pasteur pipette, transferred to 15-ml screw-cap test tubes, and stored in the dark at 4 #{176}C within 3 h of collection. Plasma lipoprotein fractionation was not affected by storage of the sample for as long as three weeks. Patients with hyperlipidemia were classified into lipoprotein phenotypes I-V by using the procedures of electrophoresis and lipoprotein fractionation detailed in the LRC manual (6).
Cholesterol Analysis
Equipment.
Cholesterol Analyzer is an enzymic oxygen-electrode cholesterol analyzer. In this system cholesterol esterase (EC 3.1.1.13) is used to hydrolyze cholesterol esters to free cholesterol; cholesterol is oxidized with cholesterol oxidase (EC 1.1.3.6) to cholest-4-en-3-one and hydrogen peroxide. Unlike other enzymic systems (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , this analyzer measures the rate (rather than the endpoint) of oxygen consumption with an oxygen electrode in place of a hydrogen peroxide-coupled reaction (11 Mixed enzyme reagent. The mixed enzyme solution was prepared by adding 600 l of the cholesterol oxidase solution to 400 tl of the cholesterol esterase solution. This"floating WI" as well as normal WI is completely removed by aspiration of the top 46% of the sample centrifuged at density 1.060kg/liter Triton X-100 (22, 23) . Activated Fat Red 7B is also Cholesterol was determined with the Beckman Cholesterol Analyzer by directly adding 10 tl of the mixed enzyme reagent to the reaction chamber or as 10 l of mixed enzyme reagent in 1 ml of sodium phosphate buffer (1 mol/liter, pH 6.0). The concentrated mixed enzyme solution was stable for at least one week at 4 #{176}C; the diluted enzyme reagent in phosphate buffer was stable for about 4 h at 37 #{176}C.
The Beckman Cholesterol Analyzer was calibrated with an aqueous cholesterol standard (2000 mg/liter, Beckman Instruments) and with three plasma poois prepared in our laboratory (950, 2370, and 3150 mg of cholesterol per liter). Five-microliter samples were routinely used for cholesterol determination; however, sample volumes up to 50 l can be used for measurement of hypolipidemic samples such as those obtained from patients with Tangier disease or abetalipoproteinemia.
Cholesterol was also determined with the Technicon AutoAnalyzer 11(6, [18] [19] [20] [21] and SMAC systems (18) (19) (20) (21) . In order to compare cholesterol values from the three instruments, a cholesterol calibration plasma (2960 mg/liter) from the Center for Disease Control, Atlanta, Ga., was used to calibrate them all. Cholesterol standards in organic reagents, routinely used in the AutoAnalyzer II, are not suitable for the aqueous systems used in the Beckman Analyzer and Technicon SMAC.
Plasma Centrifugation and Lipoprotein Fractionation
Equipment.
Plasma was centrifuged in an air-driven centrifuge (Airfuge; Beckman Instruments, Palo Alto, Calif. 94304). The rotor holds six cellulose tubes, each containing 175 iii. The centrifuge can achieve 100 000 rpm (160 000 X g) in less than 1 mm.
After centrifugation, the lipoproteins were separated into top and bottom tube fractions by aspiration (Beckman Airfuge Tube Fractionator; Beckman Instruments, Palo Alto). A schematic of the aspirator used in these studies is shown in Figure 1 . The turret holds six samples. An aspiration rate of 1-1.2 mi/s resulted in a clear separation of aspirated sample from the infranatant fraction. The aspirated sample may be collected for analysis in a 1. Plasma centrifuged at plasma density contains chylomicrons and VLDL in the top, and LDL and HDL in the bottom fraction. Plasma centrifuged at a solvent density of 1.060 kg/liter contains chylomicrons, VLDL, and LDL in the top, and HDL in the bottom fraction. Plasma lipoproteins were quantified by measuring the cholesterol content of whole plasma and the infranatant fraction of samples centrifuged at a density of plasma and 1.060 kg/liter. The cholesterol content in each of the plasma lipoprotein fractions is calculated as follows: HDL cholesterol is quantitated in the infranate of plasma centrifuged at density 1.060 kg/liter; LDL cholesterol equals the value obtained from the infranate of plasma centrifuged at plasma density (LDL plus HDL) minus the value for HDL cholesterol; VLDL cholesterol equals total plasma cholesterol minus the value for LDL plus that for HDL cholesterol. The presence of chylomicrons was ascertained by inspection of whole plasma stored at 4 #{176} C overnight, and by the appearance of chylomicrons in the ultracentrifugal top fraction of plasma centrifuged at plasma density (see Results section). The top fractions of centrifuged samples can be collected during aspiration ( Figure 1) Staining reagents. Sudan Black B stain and fixing and destaining solutions were prepared and used according to the manufacturer's (Bio-Rad) instructions for lipoprotein electrophoresis.
Procedure
Paper electrophoresis was performed as outlined in the LRC manual (6) . For agarose electrophoresis, presoaked agarose slides were drained of excess solution for 25 mm and 3 d of sample was applied with a plastic pronged applicator supplied by the manufacturer. Samples were electrophoresed at 150 V for 20-25 mm at 25 #{176}C. Electrophoresis at 4 #{176}C improved the definition of the lipoprotein bands, but extended the duration of electrophoresis to about 40 mm. Fixing, staining with Sudan Black B, and destaining were performed as outlined by the manufacturer (Bio-Rad). Densitometric scanning and integration were obtained at 590 nm with a 0.5 mm slit.
Heparin/Manganese Chloride Precipitation of Plasma for the Separation of HDL Cholesterol
Equipment.
Airfuge (Beckman Instruments). 
Procedure
Manganese chloride-containing tubes were prepared by adding 15 ILl of the manganese chloride solution to an Airfuge tube, drying under reduced pressure, and capping. Cold plasma, 150 ILl was pipetted into these tubes and mixed. Cold heparin solution, 25 ILl, was added and the contents of the tube were remixed. The centrifuge tubes were transferred to the rotor and placed on ice for 30 mm while the heparin/manganese chloride solution precipitated VLDL and LDL. The samples were then centrifuged at 100 000 rpm for 5 mm. HDL cholesterol was measured in the supernate pipetted directly from these tubes. Cholesterol values were multiplied by 1.17 to correct for dilution.
Results
Cholesterol Determinations
The within-run precision of the Beckman Cholesterol Analyzer was determined by repetitive analyses of three pooled plasma controls prepared in our laboratory. The mean values (n = 35) with one standard deviation and the coefficients of variation (CV) for the three pools were as follows: 950 ± 20 mg/liter, CV 2.1%; 2370 ± 50 mg/liter, CV 2.1%; and 3150 ± 70 mg/liter, CV 2.2%. Day-to-day precision was determined by daily analyses of one of these controls. For n = 35, the mean and SD was 2371 ± 85 mg/liter, with a CV of 3.6%. The con-
The precision of the Beckman Analyzer was also determined by using samples from patients with Tangier disease and lipoprotein phenotypes I-V. Measurements of these samples would indicate whether precision is affected by above-normal concentrations of chylomicrons (type I and V), LDL (type II), floating beta (type III), or VLDL (types IV and V). Table 1 shows results of analysis for cholesterol in samples from these patients.
We compared the Beckman Analyzer with the Liebermann.-Burchard reaction assays used in the Technicon AutoAnalyzer II (isopropranol extracted plasma) and SMAC (unextracted plasma) systems. All instruments were calibrated with a cholesterol calibration plasma supplied by the Center for Disease Control, having a stated value of 2960 mg of cholesterol per liter. Results of the Beckman Analyzer total-cholesterol method correlated well with those by the AutoAnalyzer II method (total cholesterol, range 1380-2840 mg/liter, n = 44, Yenz = l.O28xAAI1 + 45; r = 0.977), and with those results by the SMAC system (total cholesterol, range 1380-2840 mg/liter, n = 44, Yenz = l.O39XSMAC + 12; r = 0.973). For comparison, the AutoAnalyzer II method correlated with the SMAC system (total cholesterol, range 1380-2840 mg/liter, n = 44, YAAII = l.O1SXSMAC -41; r = 0.993).
Theseresultsindicatethat the BeckmanCholesterol
Analyzer is an acceptable substitute for the AutoAnalyzer II used in the LRC method for cholesterol quantitation. The response of the Beckman Cholesterol Analyzer is linear from 200-4000 mg of cholesterol per liter, it can use a sample volume of 1-50 ILl, and it has good precision with samples of various lipid composition, including lipoprotein phenotypes I-V.
Plasma Centrifugation and Lipoprotein Fractionation
Samples were centrifuged for 1-18 h. An optimal time of 2.5 h was ascertained by viewing the separation of the prestained lipoproteins, and by electrophoresis and cholesterol quantitation of the separated fractions. Prestained plasma from a normal individual (N) and from patients with lipoprotein phenotypes I-V, centrifuged for 2.5 h at 100 000 rpm and 25 #{176}C, are illustrated in Figure 2 . Prestained plasma (normal subject) centrifuged at plasma density (d = 1.006 kg/liter) contained a trace of VLDL at the top of the tube and an intensely stained band containing LDL and HDL at the bottom of the tube (Figure 2 ). The plasma sample centrifuged at a solvent density of 1.060 kg/liter had a dense band at the top, containing VLDL plus LDL, and a faintly stained band of HDL in the lower section of the tube. Each centrifuged plasma sample of phenotypes I-V demonstrated an intensely stained band characteristic of the increase in the specific lipoprotein fraction pathognomonic of the individual phenotype. Samples from patients with phenotypes I and V (fasting hyperchylomicronemia) showed an intensely stained band at the top of the tubes centrifuged at both densities. Patients with phenotype II had intensely stained bands containing LDL; prestained samples, centrifuged at plasma density, from patients with type III phenotype revealed a unique diffuse staining between VLDL and LDL due to the presence of floating beta lipoprotein, the hallmark of the type III phenotype. This diffusely stained band between VLDL and LDL was only seen in The precision of the aspiration technique was determined by gravimetric analysis of the top and bottom fractions ( Table 2 ). Mean analytical recovery was >98% with a CV of <0.5%. The small percentage of sample lost is due to the plasma remaining in the transfer tubing. Figures 4-6 illustrate the results obtained o samples from patients with phenotypes I, II, and III, which were centrifuged at the density of plasma and 1.060 kg/liter, and also the electrophoretograms of whole plasma (P) and top (T) and bottom (B) fractions of each centrifuged sample. The depth of aspiration for the samples centrifuged at a density of plasma (26%) and 1.060 kg/liter (46%) is indicated by the dashed lines.
Agarose electrophoresis of the bottom fraction of a sample centrifuged at plasma density from a patient with type I phenotype (total cholesterol, 2.061 g/liter; triglyceride, 15.293 g/liter) revealed no chylomicrons, indicating that aspiration of the sample had effectively removed the greater-than-normal concentration of chylomicrons characteristic of this disorder (Figure 4) . No significant contamination by LDL was detected in the electrophoretogram of the bottom fraction of a sample centrifuged at a density of 1.060 kg/liter from a patient with phenotype II (total cholesterol, 4.166 g/liter; triglyceride, 1.680 g/liter) ( Figure 5 ). Centrifugation of prestained plasma from a patient with type III phenotype (total cholesterol, 2.070 g/liter; triglyceride, 2.054 g/liter; VLDL cholesterol to plasma triglyceride ratiO, 0.38) showed diffuse staining between VLDL and LDL ( Figure 6 ). Upon electrophoresis of the top fraction, this sample showed the "floating beta lipoprotein" The development of the Airfuge aspirator method led to the comparison of this microtechnique with the procedure routinely used by the LRC (6). The LRC methodology requires 5 ml of plasma centrifuged for 18 h at 39 000 rpm, and quantitation of the cholesterol within the LDL plus HDL infranate after tube slicing. The precision of the micromethod and the LRC method were compared after quantifying the cholesterol in 10 separate lipoprotein fractionations of a single sample. All fractionated plasma samples were first quantified by using the Beckman Cholesterol Analyzer, in order to rule out variations between two instruments (Table 3) . Analyzer variations, as they affect the comparison of precision for the two methods, are included in the data of Table 4 . The precision, as assessed by the coefficient of variation, was better for whole plasma, HDL, and VLDL with the micro Airfuge aspirator technique (Tables 3 and 4) . The CV is greater for VLDL than LDL or HDL in both methods, at least in part due to the fact that the VLDL value is obtained by subtraction, and reflects the combined imprecision of two separate cholesterol analyses. The precision of the VLDL cholesterol quantitation with the new Airfuge aspirator method is a significant improvement when compared to the LRC method, whether a single or both cholesterol analyzers are employed (Tables 3 and 4 ). The measurement of VLDL cholesterol can be further improved (for n = 10, CV = 7.8%) by direct analysis of As a final comparison, we analyzed 15 samples obtained from normal individuals and from patients with hyperlipoproteinemia (cholesterol range, 1.700-5.120 g/liter) by both methods. The measurement of cholesterol within each lipoprotein fraction was correlated by linear regression analysis. Again, to avoid errors introduced by the measurement of cholesterol with two different analyzers, we used the Beckman Cholesterol Analyzer alone (upper panel, Table 5 (80-150mg/liter), which areoutside thelinear response ofboth cholesterol analyzers(Table5).The precision with which each cholesterol analyzermeasures the low cholesterol concentrations inHDL istherefore less than isthe casefortheotherlipoprotein fractions. This decreased precision was present even when all samples were measured with the Beckman Cholesterol Analyzer alone (upper panel, Table 5 ). Measurements of low HDL cholesterol with two separate instruments further reduced the correlation (lower panel, Table 5 ). A solution to this problem is readily apparent, because larger sample volumes (up to 50 l) can be used for cholesterol quantitation by the Beckman Cholesterol Analyzer. (The correlation coefficient for HDL cholesterol with use of 50-gil sample aliquots was 0.942.)
HDL cholesterol ismeasuredin the
Thus the Airfuge aspirator methodology appears to be reliable, fast, and precise for measuring the cholesterol in plasma lipoproteins. This method gives comparable or more precise results for the cholesterol content of lipoprotein fractions than is obtained with the LRC method. 
Discussion
Various recent reports describe the use of enzymic reactions for measuring total and free plasma cholesterol (9) (10) (11) (12) . The cholesterol esterase/cholesterol oxidase system was shown to be accurate and precise (8) (9) (10) (11) (12) , and the use of an oxygen electrode to monitor the rate of the reaction has been documented (9, (28) (29) (30) . A customer-modified Beckman glucose analyzer has been used to quantitate cholesterol (9) . This instrument was extensively studied with respect to precision of the measurements of free and total cholesterol, and as to the linearity of response with samples from individuals and patients with hyperlipoproteinemia.
The present Beckman Cholesterol Analyzer differs from the customer-modified glucose analyzer in that it monitors the reaction rate rather than endpoint, and the results are digitally displayed. The Beckman Cholesterol Analyzer gave precise, well-correlated results with a variety of hyperlipidemic samples, including patients with type Iphenotype.This isin contrast to the modified glucose analyzer, which gave a nonlinear response with ratplasma samples containing supranormal concentrations of chylomicrons.
Correlations between enzymic and colorimetric methods for cholesterol quantitation have been recently reported by several investigators (8) (9) (10) (11) (12) (13) . Direct correlation between instruments is hampered by the lack of a calibration sample that is compatible with direct analysis by all methods. In the present report, a cholesterol calibration plasma (obtained from the Center for Disease Control) was used to standardize all instruments. The slightly elevated cholesterol values (Yenz = 1.028x_11) obtainedwith the enzymic method may reflect a calibration erroror a true bias.Additional studieswillbe requiredtoascertain thesignificance of thisslight discrepancy.
In a recentreport(32) the difference in the cholesterol content of HDL isolated by centrifugation and heparin/manganese chloride precipitation was evaluated and the mean HDL cholesterol values obtained by ultracentrifugation were found to be 12 and 51 mg/liter higher for "sinking prebeta" negative and positive plasma, respectively. In the present report, the mean HDL cholesterol value obtained by the Airfuge aspirator methodology is 24 mg/liter higher than that obtained with theLRC protocol. Sinking prebeta did not appear to significantly influence the samples analyzed in this study.Electrophoretically positive "sinkingprebeta" samples can be precipitated by heparin/manganese chloride and re-analyzed (see Reagents and Procedures).
In conclusion, recentretrospective analysisof epidemiological dataemphasizingthe importanceofcholesterol within various lipoprotein fractions prompted our search for a rapid, reliable, and inexpensive method for cholesterol quantification comparable to those methods standardized by the Lipid Research Clinics. Our data demonstrate that this new micromethod is precise for the measurement of cholesterol in lipoprotein density fractions, and our results correlate well with the cholesterol values obtained with the LRC method. In addition, centrifugation of prestained plasma provides a technique for the visual inspection of the lipoprotein fractions and is particularly useful for the diagnosis of patients with type III phenotype. The small sample size and high sensitivity of the Beckman Cholesterol Analyzer make it useful for cord blood and neonate blood samples and for compositional analyses, including free and esterified cholesterol of samples obtained from ultracentrifugation, column chromatography, and metabolic studies. Fractionation of plasma lipoproteins by the Airfuge aspirator technique will facilitate the preparation of samples for analyses of apolipoprotein composition by radioimmunoassay and other immunological techniques. In addition, the lower cost of the new micromethod will enable clinical laboratories to quantitate cholesterol in the major density classes of plasma lipoproteins.
